Valliant John 的 Form 4 申報
Fusion Pharmaceuticals Inc.（FUSN），2022/3/8 申報
- 申報編號
- 0001209191-22-017150
- 申報時間
- 2022/3/8
- 交易日
- 2022/3/4-3/8
- 申報延遲
- 4 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 3 筆非衍生性交易。公開市場賣出合計 $10.4 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Valliant JohnCIK 0001813574 | 董事、高階主管（執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $7.15 to $7.53 per share. The reporting person hereby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $6.95 to $7.16 per share. The reporting person hereby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $6.83 to $7.07 per share. The reporting person hereby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。